用BCG+IL-Ⅱ行膀胱内灌注预防膀胱肿瘤复发

来源 :疾病控制杂志 | 被引量 : 0次 | 上传用户:lianjinshi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
膀胱肿瘤90%以上属移行细胞型,膀胱移行细胞癌75%~85%最初表现为表浅乳头状肿瘤,表浅细胞癌术后复发率高达40%~70%,防止肿瘤复发已成为表浅膀胱癌防治中的主要问题。我院近三年来应用BCG+IL-Ⅱ行膀胱内灌注取得较好的预防复发的效果,现报告如下。 More than 90% of bladder tumors belong to transitional cell type, and 75% ~ 85% of transitional cell carcinoma of the bladder initially manifest as superficial papillary tumors. The recurrence rate of superficial cells is as high as 40% -70% after operation, preventing recurrence of tumors has become superficial The main problems in the prevention and treatment of bladder cancer. Nearly three years my hospital application of BCG + IL-II intravesical instillation to achieve better prevention of recurrence, the report is as follows.
其他文献
提供完善的卫生服务,是认真处理好突发公共卫生事件的必要前提.它在突发事件的预警、识别和反应的三个环节中为全面收集相关信息、监控事态的发展、为领导提供决策依据、做好